Precision Biosciences (DTIL) EBIT (QoQ) (2018 - 2026)
Precision Biosciences (DTIL) EBIT (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 181.06 Mn | 152.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172.55% |
| Dec 31, 2025 | 160.52% |
| Sep 30, 2025 | 5.53% |
| Jun 30, 2025 | 1.06% |
| Mar 31, 2025 | 11.00% |
| Dec 31, 2024 | -16.78% |
| Sep 30, 2024 | -188.11% |
| Jun 30, 2024 | 676.69% |
| Mar 31, 2024 | 71.88% |
| Dec 31, 2023 | -20.44% |
| Sep 30, 2023 | -295.11% |
| Jun 30, 2023 | 76.57% |
| Mar 31, 2023 | -10.28% |
| Dec 31, 2022 | 17.49% |
| Sep 30, 2022 | 50.34% |
| Jun 30, 2022 | -8.12% |
| Mar 31, 2022 | 11.03% |
| Dec 31, 2021 | -166.19% |
| Sep 30, 2021 | -153.36% |
| Jun 30, 2021 | 215.42% |